Peter Salzmann - 16 May 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Reporting relationship: Director
Issuer ticker: CRBP
Reported as of: 16 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 May 2024, 17:00:43 UTC
Prior SEC filing: 19 Apr 2024
Next SEC filing: 24 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Sean Moran, attorney-in-fact for Peter Salzmann

Key filing fact

Peter Salzmann filed Form 4 for Corbus Pharmaceuticals Holdings, Inc. (CRBP) on 20 May 2024.

Key facts

This page summarizes Peter Salzmann's Form 4 filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 May 2024, 17:00.

Change

Previous filing in this sequence was filed on 19 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRBP transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +2,783
Change %
Price: $0.000000
Shares after: 2,783
Date: 16 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,783
Exercise price: $45.92
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.